NCT06838143 - Ilaris NIS in Korea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions

Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)TNF Receptor Associated Periodic Syndrome (TRAPS)Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD)Systemic Juvenile Idiopathic Arthritis (sJIA)

Interventions

BIOLOGICAL

Ilaris

Prospective observational study. There is no treatment allocation.